This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Jan;95(1):200.

doi: 10.1016/j.mayocp.2019.10.026.

Commercial Cannabidiol Caution: A New Gold Rush

Eugene L Scharf¹, Alexandra M Ward², Jon O Ebbert²

Affiliations

PMID: 31902417
DOI: 10.1016/j.mayocp.2019.10.026

Comment

Commercial Cannabidiol Caution: A New Gold Rush

Eugene L Scharf et al. Mayo Clin Proc. 2020 Jan.

. 2020 Jan;95(1):200.

doi: 10.1016/j.mayocp.2019.10.026.

Authors

Eugene L Scharf¹, Alexandra M Ward², Jon O Ebbert²

Affiliations

¹ Department of Neurology, Mayo Clinic, Rochester, MN.
² Primary Care Internal Medicine Research, Mayo Clinic, Rochester, MN.

PMID: 31902417
DOI: 10.1016/j.mayocp.2019.10.026

No abstract available

PubMed Disclaimer

Comment in

In reply-Commercial Cannabidiol Caution: A New Gold Rush.
VanDolah HJ, Bauer BA, Mauck KF. VanDolah HJ, et al. Mayo Clin Proc. 2020 Jan;95(1):200-201. doi: 10.1016/j.mayocp.2019.10.025. Mayo Clin Proc. 2020. PMID: 31902418 No abstract available.

Comment on

Clinicians' Guide to Cannabidiol and Hemp Oils.
VanDolah HJ, Bauer BA, Mauck KF. VanDolah HJ, et al. Mayo Clin Proc. 2019 Sep;94(9):1840-1851. doi: 10.1016/j.mayocp.2019.01.003. Epub 2019 Aug 22. Mayo Clin Proc. 2019. PMID: 31447137 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources